Metabolomics in detection of Chemotoxicity

Chemotherapy drugs capable to cause significant, irreversible, life threatening organ damage which is distressing for patients and might affect the optimal delivery of treatment. Various studies have predicted the risk factors for drug induced organ damage because of lack of biomarker to pick-up these changes in early phase causes potential morbidity and mortality. Metabolomics can address relation between gene, drugs environment and thus increase our ability to predict individual variation in drug response phenotypes.

    Related Conference of Metabolomics in detection of Chemotoxicity

    April 16-17, 2020

    16th World Congress on Structural Biology

    Amsterdam, Netherlands
    April 20-21, 2020

    11th Tissue Science and Regeneration Congress

    Kualalumpur, Malaysia
    June 28-30 2020

    globalbiotechnology-cs-2020

    June 28-30 2020

    oilgas-cs-2020

    June 28-30 2020

    BEHAVIOURAL SCIENCE-2020

    June 28-30 2020

    Bioinfo 2020

    May 10-11, 2020

    26th World Nursing & Nurse Practitioner Conference

    Yokohama, Japan
    July 17-18, 2020

    10th Glycobiology World Congress

    Vienna, Austria
    August 4-5, 2020

    12th Euro Biosensors & Bioelectronics Congress

    Zurich, Switzerland
    September 28-29, 2020

    2nd International Conference on Metabolomics, Genomics and Proteomics

    Singapore City, Singapore
    September 28-29, 2020

    19th International Conference on Structural Biology

    Barcelona, Spain
    October 08-09, 2020

    10th European Biosimilars Summit

    Milan, Italy
    October 14-15, 2020

    9th World Congress on Glycobiology & Glycochemistry

    Rome, Italy

    Metabolomics in detection of Chemotoxicity Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in